Gland Pharma informs about press release

29 Apr 2024 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it attached announcement regarding the receipt of US FDA approval for Cetrorelix Acetate for Injection, 0.25 mg/vial, Single-Dose Vial.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1781.00 7.90 (0.45%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.20
Dr. Reddys Lab 5820.00
Cipla 1423.85
Zydus Lifesciences 1008.15
Lupin 1659.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.